Global /United States /Healthcare /Biotechnology /EVFM

Evofem Biosciences, Inc.

EVFM

• OTCMKTS: EVFM • Delayed

0.0086USD -1.2%

As of 13 June 2026, Evofem Biosciences, Inc. has a market cap of $1.15M USD, ranking #48270 globally and #6186 in the United States. It ranks #4284 in the Healthcare sector, and #831 in the Biotechnology industry.

Global Rank

48270

Country Rank

6186

Sector Rank

4284

Industry Rank

831

Key Stats

Market Cap

$1.15MUSD

Enterprise Value

$60.47MUSD

Revenue (TTM)

$20.18MUSD

EBITDA (TTM)

$1.96MUSD

Net Income (TTM)

$274.0KUSD

EBITDA Margin

9.7%

Profit Margin

1.9%

PE Ratio

24.4

PS Ratio

0.1

PB Ratio

0.0

EV/EBITDA

28.9

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Biotechnology

CEO

Saundra Pelletier open_in_new

Employees

Website

evofem.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	3.6%	1.2%	-2.2%	-28%	-8.4%	-3.3%	-100%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
OTC Markets (OTCMKTS / OTC) MIC: OTCM PRIMARY	EVFM Evofem Biosciences Inc ISIN: US30048L3024 Shares Out.: Shares Outstanding: 132.53M¹ Shares Float: 132.529M² TV: TradingView: OTC: EVFM SA: Stock Analysis: OTC: EVFM YF: Yahoo Finance: EVFM GF: Google Finance: OTCMKTS: EVFM BA: Barron's: EVFM MS: Morningstar: PINX: EVFM	0.0086 USD	TV: TradingView: OTC: EVFM SA: Stock Analysis: OTC: EVFM YF: Yahoo Finance: EVFM GF: Google Finance: OTCMKTS: EVFM BA: Barron's: EVFM MS: Morningstar: PINX: EVFM

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Evofem Biosciences, Inc.

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Similar Companies

Industry: Biotechnology (United States)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 16M%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 14M%	19.0	United States
Natera, Inc. NASDAQ: NTRA	$27.6B 2M%	-	United States
IQVIA Holdings Inc. NYSE: IQV	$26.3B 2M%	20.0	United States
United Therapeutics Corp. NASDAQ: UTHR	$25.03B 2M%	20.4	United States
Moderna, Inc. NASDAQ: MRNA	$18.13B 2M%	-	United States

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
argenx SE EBR: ARGX	$47.84B 41.39B EUR 4M%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.84B 68.19T KRW 4M%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.36B 60.27B AUD 4M%	29.3	Australia
Lonza Group AG SIX: LONN	$42.3B 33.71B CHF 4M%	37.2	Switzerland
Celltrion, Inc. KRX: 068270	$28.11B 42.76T KRW 2M%	43.8	South Korea
BioNTech SE NASDAQ: BNTX	$25.69B 2M%	-	Germany

chevron_leftBack